Anticoagulant Reversal in the Setting of ICH

Description

One of the critical pieces of intracerebral hemorrhage management is achieving hemostasis of the bleed. A foundational component of this is reversing any antithrombotic drugs that the patient has on board.

This webinar will enable the clinician to discuss the clinical decision making, pharmacology, and best practices for reversal in ICH for antiplatelet, anticoagulant, and thrombolytic drugs.

About the Presenter

Dr. Zach Norman joined Blue Sky in 2021. He is a member of the Alpha Omega Alpha Honor society. His interests in neurology include neurocritical care, specifically multimodality intracranial monitoring. He earned a CFA charter during his prior career in finance. Dr. Norman is board certified in neurology and neurocritical care and has taken a leadership role at Blue Sky as a Stroke Regional Medical Director.

CME Information:

This activity has been approved for AMA PRA Category 1 Credit(s)TM.

• Release Date: 10/31/24
• Expiration Date: 10/31/25
• Estimated time to complete this activity is 1 hour